PREOPERATIVE AND POSTOPERATIVE PULMONARY REHABILITATION IN PATIENTS WITH LUNG CANCER AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE

The purpose of the study was to analyze the world experience in the objective assessment of the functional state of the bronchopulmonary system in lung cancer patients with chronic obstructive pulmonary disease (COPD) using modern diagnostic tools and techniques as well as correction of ventilation disorders in the perioperative period using long-acting inhaled bronchodilators.

Material and methods. A literature search was conducted using the Medline, Elibrary etc. databases. Out of 112 publications concerning the study of the incidence of lung cancer and COPD, external respiration function and rehabilitation of patients, 37 were included in this review.

Results. COPD was shown to be the major cause of postoperative non-surgical complications and the main predictor of perioperative mortality in lung cancer patients. Modern techniques for studying the function of external respiration, such as bodyplethysmography, spirography, high-resolution computed tomography, ventilation and perfusion lung scintigraphy, were highlighted. It was shown that preoperative correction of obstructive syndrome and postoperative pulmonary rehabilitation, including drug therapy with long-acting bronchodilators in combination with smoking cessation, eradication of foci of chronic infection and respiratory gymnastics were necessary to detect functional respiratory disorders in lung cancer patients with COPD.

Conclusion. To date, there are no standards clinical practice guidelines for diagnostic testing and the correction of ventilation disorders in lung cancer patients with COPD in the pre- and postoperative periods. Therefore, further studies aimed at developing a diagnostic algorithm to improve the accuracy of detecting bronchial obstructive syndrome, especially in the early stages of COPD, as well as compensation for respiratory disorders using modern bronchodilator therapy are needed.

1. Kaprin A.D., Starinsky V.V., Petrova G.V. Malignant neoplasms in Russia in 2016 (morbidity and mortality). Moscow; 2018. 250 p. (in Russian).

2. Merabishvili V.M. Oncological statistics (traditional methods, new information technologies): a guide for doctors. Part I. St. Petersburg, 2011. 221 p. (in Russian).

3. Bychkov M.B., Gorbunova V.A. Clinical guidelines for the diagnosis and treatment of patients with lung cancer. Moscow, 2014. 26 p. (in Russian).

4. Miller S.V., Tuzikov S.A., Goldberg V.Ye., Zavyalov A.A., Velichko S.A., Rodicheva N.S., Dobrodeyev A.Yu. Neoadjuvant chemotherapy in the multimodality treatment of non‑small cell carcinoma of the lung. Russian Journal of Oncology. 2009; 2: 31–33. (in Russian).

5. Trakhtenberg A.Kh., Kolbanov K.I. Lung cancer. Pulmonology and Allergology. 2008; 4: 3–9. (in Russian).

6. Qiang G., Liang C., Xiao F., Yu Q., Wen H., Song Z., Tian Y., Shi B., Guo Y., Liu D. Impact of chronic obstructive pulmonary disease on postoperative recurrence in patients with resected non‑small‑cell lung cancer. Int J Chron Obstruct Pulmon Dis. 2015 Dec 29; 11: 43–9. doi: 10.2147/COPD.S97411.

7. Chuchalin A.G., Avdeev S.N., Aisanov Z.R., Belevskii A.S., Leshchenko I.V., Meshcheryakova N.N., Ovcharenko S.I., Shmelev E.I. Russian respiratory society. Federal clinical guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease. Pulmonology. 2014; 3: 15–54. (in Russian).

8. Dai J., Yang P., Cox A., Jiang G. Lung cancer and chronic obstructive pulmonary disease: From a clinical perspective. Oncotarget. 2017; 8(11): 18513–18524. doi: 10.18632/oncotarget.14505.

9. Khanin A.L., Kravets S.L. Chronic obstructive pulmonary disease and tuberculosis: an actual problem in real practice. Bulletin of modern clinical medicine. 2017; 10(6): 60–70. (in Russian).

10. Kondo R., Yoshida K., Eguchi T., Kobayashi N., Saito G., Hamanaka K., Shiina T., Kurai M. Clinical features of lung cancer smokers with light and mind chronic obstructive pulmonary disease: a retrospective analysis of Japanese surgical cases. Eur J Cardiothorac Surg. 2011 Dec; 40(6): 1439–43. doi: 10.1016/j.ejcts.2011.03.017.

11. Chissov V.I., Davydov M.I. Oncology: National Leadership. Moscow; 2008. 1072 p. (in Russian).

12. Hammon J.W., Crawford F.A. The characteristics of good thoracic surgical training. J Thorac Cardiovasc Surg. 2014 Jan; 147(1): 15–7. doi: 10.1016/j.jtcvs.2013.08.072.

13. Hata A., Sekine Y., Kota O., Koh E., Yoshino I. Impact of combined pulmonary fibrosis and emphysema on surgical complications and longterm survival in patients undergoing surgery for non‑small‑cell lung cancer. Int J Chron Obstruct Pulmon Dis. 2016 Jun 9; 11: 1261–8. doi: 10.2147/COPD.S94119.

14. Hashimoto N., Iwano S., Kawaguchi K., Fukui T., Fukumoto K., Nakamura S., Mori S., Sakamoto K., Wakai K., Yokoi K., Hasegawa Y. Impact of thin‑section computed tomography‑deter‑mined combined pulmonary fibrosis and emphysema on outcomes among patients with resected lung cancer. Ann Thorac Surg. 2016 Aug; 102(2): 440–7. doi: 10.1016/j.athoracsur.2016.03.014.

15. Davydov M.I., Akchurin R.S., Gerasimov S.S., Dzemeshkevich S.L., Brand Ya.B., Dolgov I.M., Shestopalova I.M. Combined surgical treatment of cancer patients with competing cardiovascular disease in cases of tumors of the lungs and mediastinum. Surgery. 2010; 8: 4–11. (in Russian).

16. Dobrodeev A.Yu., Zav’yalov A.A., Tuzikov S.A., Miller S.V. Lung cancer: 25 years of surgical and combined treatment experience. Problems in Oncology. 2010; 56(2): 201–205. (in Russian).

17. Levashev Yu.N., Akopov A.L., El’kin A.V., Basek T.S., Kovalev M.G., Perlei V.E., Yablonskii P.K., Nikolaev G.V. Surgical treatment of lung cancer in combination with chronic obstructive pulmonary disease and tuberculosis. Bulletin of RСSC of N.N. Blokhin Russian Academy of Medical Sciences. 2003; 1: 25–28. (in Russian).

18. Burdyuk J.V., Gumerova O.N., Aznabaeva J.G., Zagidullin S.Z. Computed tomography in the diagnosis of chronic obstructive pulmonary disease. Modern problems of science and education. 2013; 6. (in Russian).

19. Ueda K., Murakami J., Tanaka T., Hayashi M., Okabe K., Hamano K. Preoperative risk assessment with computed tomography in patients undergoing lung cancer surgery. J Thorac Dis. 2018 Jul; 10(7): 4101–4108. doi: 10.21037/jtd.2018.06.111.

20. Borodina M.A., Kochetkov A.V. The results of an estimation function according to curve “stream‑volume” and bodypletizmography at patients with chronic obstructive illness of lung of advanced age. Bulletin of new medical technologies. 2011; 18(2): 411–413. (in Russian).

21. Savushkina O.I., Chernyak A.V. Clinical application of the bodypletizmography. Practical pulmonology. 2013; 2: 38–41. (in Russian).

22. Chernyavskaya G.M., Tetenev F.F., Dubakov A.V. Research methods of function of external respiration in practice of the therapist and pulmonologist. Tomsk, 2009. 102 p. (in Russian).

23. Pakhomov G.L., Khayaliev R.Ya., Ravshanov M.Kh., Yusupov Zh.U. Treatment tactic of complications after pneumonectomy. Young scientist. 2015; 7: 307–311. (in Russian).

24. Yablonskii P.K., Petrun’kin A.M., Nikolaev G.V., Mosin I.V. Changes in the functional ability of the lungs after lobectomy in patients with concomitant chronic obstructive pulmonary disease. Heralds of Surgery. 2009; 168(3): 26–30. (in Russian).

25. Parshin V.D., Belov Yu.V., Vyzhigina M.A., Charchan E.R., Parshin V.V., Golovinskii S.V. Left pneumonectomy with resection and prosthetics of the descending aorta for lung cancer. Surgery. 2010; 9: 61–63. (in Russian).

26. Petrova M.V., Kharchenko V.P. Protection of cancer patient from respiratory postoperative complications. Effective pharmacotherapy. 2015; 12: 18–21. (in Russian).

27. Merry A.F., Cooper J.B., Soyannwo O., Wilson I.H., Eichhorn J.H. International standards for a safe practice of anesthesia 2010. Can J Anaesth. 2010 Nov; 57(11): 1027–34. doi: 10.1007/s12630‑010‑9381‑6.

28. Whitaker Chair D.K., Booth H., Clyburn P., HarropGriffiths W., Hosie H., Kilvington B., Macmahon M., Smedley P., Verma R. Immediate post‑anaesthesia recovery 2013: Association of anaesthetists of Great Britain and Ireland. Anaesthesia. 2013 Mar; 68(3): 288–97. doi: 10.1111/anae.12146.

29. Cheremisina O.V., Vusik M.V., Soldatov A.N., Reiner I.B. Endoscopic laser technologies in clinical oncology. Siberian Journal of Oncology. 2007; 4: 5–11. (in Russian).

30. Saito H., Hatakeyama K., Konno H., Matsunaga T., Shimada Y., Minamiya Y. Impact of pulmonary rehabilitation on postoperative complications in patients with lung cancer and chronic obstructive pulmonary disease. Thorac Cancer. 2017 Sep; 8(5): 451–460. doi: 10.1111/1759‑7714.12466.

31. Avdeev S.N. Role of tiotropium bromide in the basic therapy of chronic obstructive pulmonary disease. Pharmateca. 2013; 15: 25–31. (in Russian).

32. Arkhipov V.V., Abrosimov A.G., Arkhipova D.E. Spiriva Respimat – a new direction in the treatment of COPD. Russian Medical Journal. 2013; 7: 379–383. (in Russian).

33. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report [Internet]. URL: www.goldcopd.com (cited 25.03.2019).

34. Chuchalin A.G. Pulmonology. National Leadership. Moscow; 2016. 800 p. (in Russian).

35. Karner C., Chong J., Poole P. Tiotropium versus placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014 Jul 21; (7): CD009285. doi: 10.1002/14651858.CD009285.pub3.

36. Nojiri T., Inoue M., Yamamoto K., Maeda H., Takeuchi Y., Nakagiri T., Shintani Y., Minami M., Sawabata N., Okumura M. Inhaled tiotropium to prevent postoperative cardiopulmonary complications in patients with newly diagnosed chronic obstructive pulmonary disease requiring lung cancer surgery. Surg Today. 2014 Feb; 44 (2): 285–90. doi: 10.1007/s00595‑012‑0481‑5.

37. Takegahara K., Usuda J., Inoue T., Ibi T., Sato A. Preoperative management using inhalation therapy for pulmonary complications in lung cancer patients with chronic obstructive pulmonary disease. Gen Thorac Cardiovasc Surg. 2017 Mar 9; 65 (7): 388–391. doi: 10.1007/s11748‑017‑0761‑5.